New Science Ventures, founded in 2004, is a New York-based venture fund focusing on SpaceTech investments at various stages including Seed, Series A, Series B, Series C, and Series D. With a portfolio that includes companies like Phase Four, the fund has made 74 investments and has seen 18 successful exits. Tom Lavin is a partner at New Science Ventures, and the fund primarily targets life sciences and information technology sectors. For more details, visit their website at www.newscienceventures.com.